Variables | Subjects with NAFLD (n = 349) Mean ± SD | Subjects without NAFLD (n = 927) Mean ± SD | P value |
---|---|---|---|
Gender, n (%) | |||
female | 102 (29.2) | 500 (53.7) | <.0001 |
male | 247 (70.8) | 427 (46.1) | |
Age | 47.7 ± 11.5 | 38.0 ± 12.1 | <.0001 |
BMI | 29.7 ± 4.7 | 24.0 ± 3.7 | <.0001 |
WHR | 0.9 ± 0.1 | 0.8 ± 0.1 | <.0001 |
ALT | 20.9 ± 10.3 | 13.5 ± 5.8 | <.0001 |
AST | 11.2 ± 5.1 | 9.0 ± 2.6 | <.0001 |
GGT | 20.5 ± 20.6 | 11.0 ± 10.5 | <.0001 |
TSH (μU/ml) | 1.8 ± 1.4 | 1.8 ± 3.5 | 0.6381 |
TT3 (nmol/l) | 1.6 ± 0.3 | 1.6 ± 0.3 | 0.3293 |
TT4 (nmol/l) | 83.2 ± 15.6 | 92.0 ± 17.4 | 0.0004 |
Anti-TPO (IU/ml) | 23.9 ± 72.1 | 23.9 ± 74.0 | 0.4063 |
Diabetes, n (%) | 22 (6.3) | 8 (0.9) | <.0001 |
Metabolic syndrome, n (%) | 65 (18.6) | 15 (1.6) | <.0001 |
Hypertension, n (%) | 99 (28.4) | 67 (7.2) | <.0001 |